Literature DB >> 26252459

Evaluating innovation. Part 2: Development in neurosurgery.

Zane Schnurman1, Douglas Kondziolka1.   

Abstract

OBJECT Patients, practitioners, payers, and regulators are advocating for reform in how medical advances are evaluated. Because surgery does not adhere to a standardized developmental pathway, how the medical community accepts a procedure remains unclear. The authors developed a new model, using publication data and patterns, that quantifies this process. Using this technique, the authors identified common archetypes and influences on neurosurgical progress from idea inception to acceptance. METHODS Seven neurosurgical procedures developed in the past 15-25 years were used as developmental case studies (endovascular coil, deep brain stimulation, vagus nerve stimulation, 1,3-bis(2-chloroethyl)-l-nitrosourea wafer, and 3 radiosurgery procedures), and the literature on each topic was evaluated. A new metric the authors termed "progressive scholarly acceptance" (PSA) was used as an end point for community acceptance. PSA was reached when the number of investigations that refine or improve a procedure eclipsed the total number of reports assessing initial efficacy. Report characteristics, including the number of patients studied, study design, and number of authoring groups from the first report to the point of PSA, were assessed. RESULTS Publication data implicated factors that had an outsized influence on acceptance. First, procedural accessibility to investigators was found to influence the number of reports, number of patients studied, and number of authoring groups contributing. Barriers to accessibility included target disease rarity, regulatory restrictions, and cost. Second, the ease or difficulty in applying a randomized controlled trial had an impact on study design. Based on these 2 factors, 3 developmental archetypes were characterized to generally describe the development of surgery. CONCLUSIONS Common surgical development archetypes can be described based on factors that impact investigative methods, data accumulation, and ultimate acceptance by society. The approach and proposed terminologies in this report could inform future procedural development as well as any attempts to regulate surgical innovation.

Entities:  

Keywords:  BCNU = 1,3-bis(2-chloroethyl)-l-nitrosourea; CMS = Centers for Medicare and Medicaid Services; DBS = deep brain stimulation; ET = essential tremor; GDC = Guglielmi detachable coil; LCD = local coverage determination; PSA = progressive scholarly acceptance; RCT = randomized controlled trial; SRS = stereotactic radiosurgery; TN = trigeminal neuralgia; VNS = vagus nerve stimulation; innovation; model; neurosurgery; science

Mesh:

Substances:

Year:  2015        PMID: 26252459     DOI: 10.3171/2015.1.JNS142664

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

Review 1.  Global trends in paediatric robot-assisted urological surgery: a bibliometric and Progressive Scholarly Acceptance analysis.

Authors:  Thomas P Cundy; Simon J D Harley; Hani J Marcus; Archie Hughes-Hallett; Sanjeev Khurana
Journal:  J Robot Surg       Date:  2017-04-28

2.  The risk of cataractogenesis after gamma knife radiosurgery: a nationwide population based case-control study.

Authors:  Cheng-Loong Liang; Po-Chou Liliang; Tai-Been Chen; Huan-Chen Hsu; Fu-Cheng Chuang; Kuo-Wei Wang; Hao-Kuang Wang; San-Nan Yang; Han-Jung Chen
Journal:  BMC Ophthalmol       Date:  2017-04-04       Impact factor: 2.209

Review 3.  Simulation for skills training in neurosurgery: a systematic review, meta-analysis, and analysis of progressive scholarly acceptance.

Authors:  Joseph Davids; Susruta Manivannan; Ara Darzi; Stamatia Giannarou; Hutan Ashrafian; Hani J Marcus
Journal:  Neurosurg Rev       Date:  2020-09-18       Impact factor: 3.042

4.  Robot-assisted stereotactic brain biopsy: systematic review and bibliometric analysis.

Authors:  Hani J Marcus; Vejay N Vakharia; Sebastien Ourselin; John Duncan; Martin Tisdall; Kristian Aquilina
Journal:  Childs Nerv Syst       Date:  2018-05-10       Impact factor: 1.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.